Bridge to recovery using an Impella 2.5 device in a 3-year-old child

Kira Kuschnerus1,2, Christoph Starck3, Evgenij Potapov3

  • 1Department of Congenital Heart Surgery-Pediatric Heart Surgery, German Heart Center Berlin, Berlin, Germany.

Insights

Mechanical circulatory support is limited for pediatric acute left ventricular failure. A 3-year-old child with post-transplant rejection was successfully bridged to recovery using a novel Impella 2.5 device.

Area of Science:

  • Pediatric cardiology
  • Mechanical circulatory support
  • Cardiac transplantation

Background:

  • Mechanical support for pediatric acute left ventricular failure is limited, primarily to extracorporeal life support (ECLS) or ventricular assist devices (VADs).
  • Acute humoral rejection post-cardiac transplantation can lead to persistent low cardiac output syndrome, posing significant management challenges in children.

Observation:

  • A 3-year-old child (12 kg) presented with persistent low cardiac output syndrome due to acute humoral rejection after cardiac transplantation, unresponsive to medical therapy.
  • The clinical team opted for an alternative mechanical support strategy due to the limitations of conventional options.

Findings:

  • A 2.5 version of the Impella device was successfully implanted using a 6-mm Hemashield prosthesis in the right axillary artery.
  • This intervention effectively stabilized the patient's hemodynamics, providing crucial support.

Implications:

  • This case demonstrates the potential utility of the Impella 2.5 device as a bridge to recovery in pediatric patients experiencing severe low cardiac output syndrome post-cardiac transplantation.
  • The successful application highlights a potentially viable alternative mechanical circulatory support option in challenging pediatric cardiac scenarios.
  • Further investigation into the use of percutaneous ventricular assist devices in pediatric transplantation is warranted.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
15
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
24
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
21